| 期 |
栏目 |
标题 |
文件 |
| 卷 16, 编号 1 (2014) |
Articles |
Renal involvement in children with non-Hodgkin lymphomas |
|
| 卷 17, 编号 4 (2015) |
Articles |
Current possibilities in diagnosis and treatment of diffuse large B cell lymphoma in children and adolescents: results of Pediatric Hematology and Oncology Research Institute of N.N.Blokhin Russian Cancer Research Center, international experience |
|
| 卷 17, 编号 5 (2015) |
Articles |
Modern aspects of differential diagnosis and treatment of large B-cell lymphomas with mediastinum involvement in children and adolescents |
|
| 卷 18, 编号 1 (2016) |
Articles |
Long-term effects of pediatric cancer therapy: 35-year clinical experience |
(Rus)
|
| 卷 19, 编号 3 (2017) |
Articles |
The predictive role of interim pet-ct in the treatment of hodgkin's lymphoma in children |
(Rus)
|
| 卷 20, 编号 1 (2018) |
Articles |
Epstein-Barr virus in children with classical Hodgkin’s lymphoma |
(Rus)
|
| 卷 21, 编号 2 (2019) |
Articles |
Quality of life and psychological status of thoracic and abdominal pediatric cancer survivors |
(Rus)
|
| 卷 21, 编号 4 (2019) |
CLINICAL ONCOLOGY |
Possibilities of epigenetic therapy of acute myeloid leukemias in children |
(Rus)
|
| 卷 21, 编号 4 (2019) |
CLINICAL ONCOLOGY |
Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children |
(Rus)
|
| 卷 22, 编号 4 (2020) |
CLINICAL ONCOLOGY |
Ifosfamide/cyclofosfamide-induced methemoglobinemia in pediatric patients with hemoblastoses |
(Rus)
|
| 卷 23, 编号 1 (2021) |
CLINICAL ONCOLOGY |
Detection and monitoring of minimal residual disease in acute megakaryoblastic leukemia in children |
(Rus)
|
| 卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Role of pharmacogenetic factors in the development of side effects of methotrexate in the treatment of malignant tumors: A review |
(Rus)
|
| 卷 24, 编号 3 (2022) |
CLINICAL ONCOLOGY |
Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience |
(Rus)
|
| 卷 25, 编号 1 (2023) |
CLINICAL ONCOLOGY |
Targeted therapy and hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in pediatric and adolescent patients: a pilot protocol results |
(Rus)
|
| 卷 25, 编号 1 (2023) |
CLINICAL ONCOLOGY |
The role of minimal residual disease in therapy of pediatric acute lymphoblastic leukemia: a prospective cohort study |
(Rus)
|
| 卷 25, 编号 3 (2023) |
CLINICAL ONCOLOGY |
International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review) |
(Rus)
|
| 卷 26, 编号 1 (2024) |
Articles |
Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study |
(Rus)
|
